Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.

Gene Expression Humans Integrins / genetics Melanoma / genetics Osteopontin / genetics Prognosis Protein Isoforms / genetics Skin Neoplasms / genetics Melanoma, Cutaneous Malignant
gene expression integrins melanoma progression osteopontin osteopontin splice variants

Journal

Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087

Informations de publication

Date de publication:
2022
Historique:
received: 19 05 2022
accepted: 11 07 2022
entrez: 12 9 2022
pubmed: 13 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

Osteopontin (OPN) is a multifunctional glycoprotein that physiologically interacts with different types of integrins. It is considered to be a possible prognostic biomarker in certain tumor types; however, various splicing isoforms exist, which have not been investigated in melanoma. We aimed to define the relative expression pattern of five

Identifiants

DOI: 10.3389/pore.2022.1610608 PMID: 36091936 PMC: PMC9448871
pubmed: 36091936
doi: 10.3389/pore.2022.1610608
pii: 1610608
pmc: PMC9448871
doi:

Substances chimiques

Integrins 0
Protein Isoforms 0
SPP1 protein, human 0
Osteopontin 106441-73-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610608

Informations de copyright

Copyright © 2022 Jámbor, Koroknai, Kiss, Szász, Pikó and Balázs.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Oncol. 2019 Feb;54(2):420-430
pubmed: 30535434
Pathol Oncol Res. 2021 Mar 05;27:581395
pubmed: 34257527
Cancers (Basel). 2021 Jul 28;13(15):
pubmed: 34359694
Immunol Res. 2011 Apr;49(1-3):160-72
pubmed: 21136203
Biomedicines. 2021 Oct 01;9(10):
pubmed: 34680488
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):494-9
pubmed: 25550515
Int J Dermatol. 2020 May;59(5):525-534
pubmed: 32157692
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Cell Mol Med. 2010 Aug;14(8):2037-44
pubmed: 20597997
Cancer Res. 2009 Sep 15;69(18):7320-8
pubmed: 19738067
Semin Cancer Biol. 2015 Dec;35:145-53
pubmed: 26297892
Oncol Lett. 2019 Mar;17(3):2592-2598
pubmed: 30854034
Mod Pathol. 2020 Jan;33(Suppl 1):15-24
pubmed: 31758078
Melanoma Res. 2017 Jun;27(3):180-188
pubmed: 28234767
Cancers (Basel). 2021 Dec 01;13(23):
pubmed: 34885166
JNCI Cancer Spectr. 2020 Oct 23;4(6):pkaa097
pubmed: 33409460
Oncol Rep. 2014 Jan;31(1):262-72
pubmed: 24173498
Melanoma Res. 2021 Aug 1;31(4):283-289
pubmed: 34039941
J Clin Invest. 2011 Jan;121(1):226-37
pubmed: 21135504
Melanoma Res. 2019 Aug;29(4):390-400
pubmed: 30741840
Cells. 2021 Jul 19;10(7):
pubmed: 34359989
Curr Atheroscler Rep. 2009 May;11(3):206-13
pubmed: 19361352
J Exp Clin Cancer Res. 2018 Apr 27;37(1):92
pubmed: 29703238
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):93-108.A
pubmed: 28254527
Matrix Biol. 2005 Sep;24(6):418-27
pubmed: 16005200
J Thromb Haemost. 2005 Jul;3(7):1511-21
pubmed: 15978109
Cancer. 2008 Jan 1;112(1):144-50
pubmed: 18023025
Histopathology. 1994 Mar;24(3):249-56
pubmed: 7515372
PLoS One. 2013;8(1):e54958
pubmed: 23383013
Mol Cancer Res. 2011 Mar;9(3):280-93
pubmed: 21263033
J Diabetes Metab Disord. 2014 Jan 08;13(1):13
pubmed: 24401206
Oncotarget. 2017 Jan 3;8(1):215-227
pubmed: 27966446
Cells. 2019 Aug 02;8(8):
pubmed: 31382483
Mol Biol Rep. 2020 Oct;47(10):8339-8345
pubmed: 33006711
Adv Exp Med Biol. 2014;819:41-60
pubmed: 25023166
Tumour Biol. 2015 Sep;36(10):7841-7
pubmed: 25944164
Oncotarget. 2015 Sep 8;6(26):22239-57
pubmed: 26068949
Pharmacol Res. 2019 Jun;144:235-244
pubmed: 31028902
PLoS One. 2010 Jan 15;5(1):e8743
pubmed: 20090957
Cytokine Growth Factor Rev. 2019 Dec;50:19-28
pubmed: 31126876
J Biol Chem. 2011 Apr 1;286(13):11170-8
pubmed: 21321126
Oncotarget. 2017 Mar 7;8(10):16340-16355
pubmed: 28030801
Oncotarget. 2016 Aug 23;7(34):55572-55584
pubmed: 27487131
Genes Dis. 2018 Dec 31;6(1):16-24
pubmed: 30906828
Oncogene. 2006 Apr 6;25(15):2192-202
pubmed: 16288209
Int J Mol Med. 2017 Jun;39(6):1327-1337
pubmed: 28440483
Cancer Epidemiol. 2013 Dec;37(6):985-92
pubmed: 24012693
Cancer Invest. 2021 Jul-Aug;39(6-7):559-570
pubmed: 34043476
Cancer. 1999 Jan 15;85(2):375-82
pubmed: 10023705

Auteurs

Krisztina Jámbor (K)

Doctoral School of Health Sciences, University of Debrecen, Debrecen, Hungary.
Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Viktória Koroknai (V)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
ELKH-DE Public Health Research Group, University of Debrecen, Debrecen, Hungary.

Tímea Kiss (T)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

István Szász (I)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
ELKH-DE Public Health Research Group, University of Debrecen, Debrecen, Hungary.

Péter Pikó (P)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
ELKH-DE Public Health Research Group, University of Debrecen, Debrecen, Hungary.

Margit Balázs (M)

Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
ELKH-DE Public Health Research Group, University of Debrecen, Debrecen, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Expression des gènes › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Intégrines › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Ostéopontine › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Diagnostic › Pronostic › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Isoformes de protéines › Gene Expression Patterns of Osteopontin...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › Gene Expression Patterns of Osteopontin...